Biliary Tract Cancer Clinical Trials in Hangzhou, Zhejiang
7 recruitingHangzhou, Zhejiang, China
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Biliary Tract Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.102 enrolled43 locationsNCT06431490
Recruiting
Phase 1
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Gastric CancerEsophageal AdenocarcinomaMetastatic Cancer+5 more
I-Mab Biopharma US Limited330 enrolled21 locationsNCT04900818
Recruiting
Phase 3
A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)
Advanced Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.604 enrolled1 locationNCT07229625
Recruiting
Phase 2
Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer
Biliary Tract CancerCholangiocarcinomaGall Bladder Cancer+1 more
First Affiliated Hospital of Zhejiang University60 enrolled1 locationNCT07025174
Recruiting
Early Phase 1
CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
Biliary Tract CancerColorectal CarcinomaGastric Cancer, Metastatic+2 more
Zhejiang University18 enrolled1 locationNCT06937567
Recruiting
Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers
Liver CancerPancreatic CancerBiliary Tract Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University1,608 enrolled1 locationNCT06139042
Recruiting
Phase 2
Adebrelimab With or Without SHR-8068 in Combination With Cisplatin Plus Gemcitabine as First-line Treatment in Patients With Advanced Biliary Tract Cancer
Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.80 enrolled1 locationNCT06465563